Global oculoplastic surgery market was worth USD 7.1 billion in 2018. It is forecast to grow at a CAGR (5.72%) during the forecast period. This growth is mainly due to increased consumer awareness and a growing geriatric population susceptible to the signs of aging. The market is also being driven by the availability of safer and more affordable procedures thanks to technological advances. Market growth is expected to be driven by a growing urban population and the availability of multiple procedures. There are also increasing numbers of plastic surgeons around the world.
Oculoplastic surgery, also known as ocular plastic surgery, refers to procedures that are performed around the eyelids, orbits, and/or face. Oculoplastic surgery is generally done to improve the appearance of patients. Oculoplastic surgery is expected to grow because of the advancements in non-invasive methods that offer benefits such as quick recovery and same-day procedures. These procedures have been shown to reduce the risk of complications after surgery, which will be a boon for market growth.
Market growth is expected to be aided by the increasing prevalence of eye-related conditions such as blurry vision and wrinkles near the eyes. The American Society of Aesthetic Plastic Surgery reports that more than 1.3 million eyelid surgeries were performed worldwide in 2017. In the same year, 17 million procedures for plastic surgery were performed in the United States alone. The future growth of the market for oculoplastic surgeries will be influenced by the development of more medical tourism as well as improved reimbursement policies in both developing and developed economies.
Other factors that are driving market growth include rising disposable income, acceptance of various oculoplastic surgery, and willingness to invest in aesthetic surgeries. Consumers in the medical aesthetics market have been influenced by celebrities and social media. Multiple studies in the U.K. have shown that 55% of facial surgeons reported that patients were motivated by the desire to look better in selfies, up from 13% in 2016. There is a growing demand for aesthetic medical procedures offered by beauty salons. They are constantly pledging to improve their equipment. The advent of minimally invasive surgery may limit the demand for oculoplastic procedures during the forecast period.
In 2018, the eyelid surgery segment was the most important. The largest market size in 2018 was for eyelid surgery Also known as blepharoplasty or eyelift, this procedure removes excess skin and bags from the upper eyelids. The segment is expected to grow due to a growing geriatric population that is more susceptible to vision impairments and problems such as sagging eyelids.
In 2018, the browlift and facial segment was valued at USD 557.40 millions. It is projected to grow at 6.23% CAGR during the forecast period. This segment's high growth rate is due to its benefits, including reducing eye bags and puffiness under the eyes and tightening the soft tissues around the forehead for a younger appearance. According to statistics from the American Society of Aesthetic Plastic Surgery, there were approximately 249,343 procedures for brow lifts in 2017. This number is forecast to rise significantly over the forecast period.
The market share for ambulance surgical centers was over 60% in 2018. This segment will continue to dominate the market during the forecast period. This is due to an increasing number of outpatient procedures that don't require hospitalization. The availability of an ambulatory surgery centre has helped transform healthcare facilities and the market for medical equipment. These centers offer surgical procedures at a fraction of the cost of hospitals. There were 5,700 ambulatory surgery centers in the United States with a combined revenue of USD 35 billion.
The hospital segment is expected to see significant growth over the forecast period. This segment is driven by the increasing incidence of eye diseases, the development of healthcare infrastructure, rising healthcare spending, and the increasing private sector. Segment growth is also driven by factors like the availability of highly qualified surgeons as well as advanced medical equipment.
Due to its growing market share and high costs of treatment, North America dominated the market in 2018. North America is home to a large population. The millennial aesthetic use rate has tripled in the last four years. The high number of procedures performed in the United States made the U.S the dominant regional market in oculoplastic surgeries in that same year. According to the American Society of Aesthetic Plastic Surgeons, blepharoplasty-removal of excess tissue around the eyelids-is one of the most common cosmetic procedures performed in the country. In the United States, 115,000 blepharoplasty surgeries were performed in 2018.
Asia Pacific will experience the fastest CAGR (6.62%) during the forecast period. Regional growth is driven by the differences in plastic surgery costs between developed and developing countries. Japan leads the APAC region due to its large population of beauty-conscious people and growing aging population. The International Society of Aesthetic Plastic estimates that approximately 90% of cosmetic surgery performed on the face was done in 2017. The rise in eye-related surgery is expected to drive Latin America's growth in the future. According to the International Society of Aesthetic Plastics, Brazil had 159,720 eyelid surgeries in 2017. This is higher than the U.S. (141 505)
Integra Life Sciences, Sklar Surgical Instruments, TEKNOMEDICAL Optik–Chirurge GmbH; Stanford Health Care. These companies are looking to collaborate and launch new products to offer advanced services to patients undergoing oculoplastic surgeries around the world.
This report provides a forecast of revenue growth at the global, regional and country level as well as an analysis of industry trends in each sub-segment from 2015 to 2026. Grand View Research has divided the global oculoplastic surgeon market report by procedure, end use and region.
Procedure (Revenue USD Million, 2015-2026)
Eyelid Surgery
Face Lift
Brow Lift & Forehead Lift
Pediatric Oculoplastic Surgery
Orbital Surgery
End Use Type (Revenue in USD Millions, 2015-2026)
Hospitals & Clinics
Ambulatory Surgical Centers
Regional Outlook (Revenue USD Million, 2015-2026)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. Global oculoplastic surgery market was valued at USD 7,481.8 Million in 2019. It is projected to grow to USD 7,894.0 Million in 2020.
How is the market for oculoplastic surgeries growing?b. Global oculoplastic surgery is forecast to grow at a compound annual rate of 5.7% between 2019 and 2026, reaching USD 11,047.2 million in 2026.
Which segment had the largest market share in oculoplastic surgeries?b. With a 30.2% share in 2019, North America dominated the market for oculoplastic surgeries. This is due to the increasing number of procedures, the large population and millennial aesthetic user rates, as well as the high price of the treatment.
What are the major players in the oculoplastic market?b. b.
What are the driving factors for the oculoplastic market?b. The market growth is being driven by technological advancements, increasing eye-related conditions, and an increase in the number of age-related Oculoplastic surgery.
Up Market Research published a new report titled “Oculoplastic Surgery Market research report which is segmented by End Use (Ambulatory Surgical Centers, Hospitals, Clinics), by Procedure (Eyelid, Orbital Pediatric, Brow Lift, Face Lift), By Players/Companies Inc; Stanford Health Care; B Braun Melsungen AG; Blink Medical Ltd; Shoyukai; Bolton Surgical Ltd; Integra Life Sciences; Karlz Storz; and BMT Medizintechnik GmbH, Integra Life Sciences; Sklar Surgical Instruments; TEKNO-MEDICAL Optik-Chirurge GmbH; Stanford Health Care; Zimmer Biomet holdings”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Oculoplastic Surgery Market Research Report |
By End Use | Ambulatory Surgical Centers, Hospitals, Clinics |
By Procedure | Eyelid, Orbital Pediatric, Brow Lift, Face Lift |
By Companies | Inc; Stanford Health Care; B Braun Melsungen AG; Blink Medical Ltd; Shoyukai; Bolton Surgical Ltd; Integra Life Sciences; Karlz Storz; and BMT Medizintechnik GmbH, Integra Life Sciences; Sklar Surgical Instruments; TEKNO-MEDICAL Optik-Chirurge GmbH; Stanford Health Care; Zimmer Biomet holdings |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 232 |
Number of Tables & Figures | 163 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by End Use (Ambulatory Surgical Centers, Hospitals, Clinics), by Procedure (Eyelid, Orbital Pediatric, Brow Lift, Face Lift).
Oculoplastic Surgery Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Oculoplastic Surgery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Oculoplastic Surgery Market Report:
Some other reports from this category!